Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
New analyses show that the long-acting injections may be even more effective than previously reported.
Awareness of the HIV prevention pills don’t match their use.
Injections given every month or every other month were preferred over daily pills.
The agency will accept public comment on the proposed guidelines during two webinars on May 24 and 25.
Injectable cabotegravir and rilpivirine are approved for people with viral suppression who would prefer monthly injections to daily pills.
Injectable cabotegravir and rilpivirine are approved for people with viral suppression who want monthly injections instead of daily pills.
A study finds that long-acting cabotegravir is an effective PrEP option for women.
Cabotegravir injections and daily Truvada are both highly effective, but some people may find it easier to use the long-acting regimen.
Monthly islatravir pills are just one of the long-acting options in the HIV prevention pipeline.
Whether for treatment or prevention, women’s interest in injectable antiretrovirals varied based on their relationship with injection.
COVID-19, HIV vaccines, cure news and long-acting injectables stood out among the top HIV treatment stories of the year.
The European Medicines Agency gave the green light to injectable cabotegravir and rilpivirine for HIV treatment.
A study analyzed how well people with HIV and their health care providers can navigate the experimental long-acting injectable Cabenuva.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.